Long-term safety and efficacy of 24-hour levodopa-carbidopa intestinal gel in Parkinson's disease. [electronic resource]
- Movement disorders : official journal of the Movement Disorder Society 11 2019
- 1747-1748 p. digital
Publication Type: Letter
1531-8257
10.1002/mds.27883 doi
Aged Antiparkinson Agents--therapeutic use Carbidopa--therapeutic use Drug Combinations Female Humans Levodopa--therapeutic use Male Middle Aged Parkinson Disease--drug therapy Treatment Outcome